Nevertheless, the prognostic value of TAMs-secreted CCL5 for prostate cancer as well as its modulatory effect on both prostate cancer cells and PCSCs cells remain unclear and deserve further investigations. This evidence concerns the gene CCL5 and Familial prostate cancer.